Related references
Note: Only part of the references are listed.Discovery and optimization of tetrahydropyrido[4,3-d]pyrimidine derivatives as novel ATX and EGFR dual inhibitors
Tongfei Jing et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis
Manuel Baader et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation
Anand Balupuri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model
Aikaterini Nikolaou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation
Matthew G. K. Benesch et al.
CANCERS (2018)
Autotaxin inhibitors: a patent review (2012-2016)
Aikaterini Nikolaou et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Hepatocyte Autotaxin Expression Promotes Liver Fibrosis and Cancer
Eleanna Kaffe et al.
HEPATOLOGY (2017)
Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis
Pengxiu Cao et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity
Shuhong Sun et al.
JOURNAL OF LIPID RESEARCH (2017)
Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors
Agnes Joncour et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells
Souvik Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators
Willem-Jan Keune et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode
Lisa M. Miller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis
Nicolas Desroy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
K. Schmitz et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
Tomoo Yamazaki et al.
SCIENTIFIC REPORTS (2017)
Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors
Anand Balupuri et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis
Gretchen Bain et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Discovery of potent inhibitors of the lysophospholipase autotaxin
Pritom Shah et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature
Diana Castagna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program
Cody Kime et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design
Spencer B. Jones et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling
Willem-Jan Keune et al.
NATURE COMMUNICATIONS (2016)
An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis
Flavia V. Castelino et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma
Mandi M. Murph et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer
Efrosini Barbayianni et al.
PROGRESS IN LIPID RESEARCH (2015)
Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding
Adam J. Stein et al.
MOLECULAR PHARMACOLOGY (2015)
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
Heather B. Streeter et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis
Chloe Rancoule et al.
BIOCHIMIE (2014)
Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice
Matthew G. K. Benesch et al.
FASEB JOURNAL (2014)
Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif
James I. Fells et al.
FEBS JOURNAL (2014)
Increased autotaxin activity in multiple sclerosis
Hamid Zahednasab et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation In Vivo and Regulates Urethral Tension
Hiroshi Saga et al.
PLOS ONE (2014)
Dendrimer Conjugate of [4-(Tetradecanoylamino)benzyl]phosphonic Acid (S32826) as an Autotaxin Inhibitor
Natalie Fisher et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Screening and X-ray Crystal Structure-based Optimization of Autotaxin (ENPP2) Inhibitors, Using a Newly Developed Fluorescence Probe
Mitsuyasu Kawaguchi et al.
ACS CHEMICAL BIOLOGY (2013)
Lysophosphatidic Acid Receptor-2 Deficiency Confers Protection against Bleomycin-Induced Lung Injury and Fibrosis in Mice
Long Shuang Huang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
PF-8380 and Closely Related Analogs: Synthesis and StructureActivity Relationship towards Autotaxin Inhibition and Glioma Cell Viability
Patrick-Denis St-Coeur et al.
ARCHIV DER PHARMAZIE (2013)
Lysophosphatidic acid (LPA) and its receptors: Role in airway inflammation and remodeling
Yutong Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: A focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays
Semjon Willier et al.
BIOLOGY OF THE CELL (2013)
Autotaxin inhibitors: a patent review
Efrosini Barbayianni et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
The Polybasic Insertion in Autotaxin α Confers Specific Binding to Heparin and Cell Surface Heparan Sulfate Proteoglycans
Anna J. S. Houben et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Metabolically-Stabilized Phosphonate Analog of Lysophosphatidic Acid Attenuates Collagen-Induced Arthritis
Ioanna Nikitopoulou et al.
PLOS ONE (2013)
Autotaxin inhibition with PF-8380 enhances the radiosensitivity of human and murine glioblastoma cell lines
Sandeep R. Bhave et al.
FRONTIERS IN ONCOLOGY (2013)
Hits of a High-Throughput Screen Identify the Hydrophobic Pocket of Autotaxin/Lysophospholipase D As an Inhibitory Surface
James I. Fells et al.
MOLECULAR PHARMACOLOGY (2013)
Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
Nikos Oikonomou et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Chemical Evolution of Autotaxin Inhibitors
Harald M. H. G. Albers et al.
CHEMICAL REVIEWS (2012)
Identification and biochemical characterization of a novel autotaxin isoform, ATX delta, with a four-amino acid deletion
Takafumi Hashimoto et al.
JOURNAL OF BIOCHEMISTRY (2012)
Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts
Yimin Qian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Aromatic phosphonates inhibit the lysophospholipase D activity of autotaxin
Guowei Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Benzyl and Naphthalene Methylphosphonic Acid Inhibitors of Autotaxin with Anti-invasive and Anti-metastatic Activity
Renuka Gupte et al.
CHEMMEDCHEM (2011)
Autotaxin as a novel serum marker of liver fibrosis
Hayato Nakagawa et al.
CLINICA CHIMICA ACTA (2011)
Structure-Based Design of Novel Boronic Acid-Based Inhibitors of Autotaxin
Harald M. H. G. Abers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Insights into autotaxin: how to produce and present a lipid mediator
Wouter H. Moolenaar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Structural basis of substrate discrimination and integrin binding by autotaxin
Jens Hausmann et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Crystal structure of autotaxin and insight into GPCR activation by lipid mediators
Hiroshi Nishimasu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid
Renuka Gupte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX)
James E. East et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression
N. Panupinthu et al.
BRITISH JOURNAL OF CANCER (2010)
A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
J. S. Swaney et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Evaluation of Inhibitory Actions of Flavonols and Related Substances on Lysophospholipase D Activity of Serum Autotaxin by a Convenient Assay Using a Chromogenic Substrate
Kaori Ueda et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Optimization of a Pipemidic Acid Autotaxin Inhibitor
Adrienne B. Hoeglund et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery and Optimization of Boronic Acid Based Inhibitors of Autotaxin
Harald M. H. G. Albers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
Molly K. Altman et al.
MOLECULAR CANCER (2010)
Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation
Harald M. H. G. Albers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance
Mu-En Lin et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation
James Gierse et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs
E. Jeffrey North et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases
Shuying Liu et al.
CANCER CELL (2009)
Phosphatase-resistant analogues of lysophosphatidic acid: Agonists promote healing, antagonists and autotaxin inhibitors treat cancer
Glenn D. Prestwich et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Lysophosphatidic acid and renal fibrosis
Jean-Philippe Pradere et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
α- and β-Substituted phosphonate analogs of LPA as autotaxin inhibitors
Peng Cui et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Molecular pharmacology of adipocyte-secreted autotaxin
Natacha Moulharat et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Murine and human autotaxin α, β, and γ isoforms -: Gene organization, tissue distribution, and biochemical characterization
Adeline Giganti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
S32826, A Nanomolar Inhibitor of Autotaxin: Discovery, Synthesis and Applications as a Pharmacological Tool
Gilles Ferry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion
Lauren P. Saunders et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
Andrew M. Tager et al.
NATURE MEDICINE (2008)
Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity
Naoko Watanabe et al.
LIFE SCIENCES (2007)
Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors
Peng Cui et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands
GG Durgam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors
V Gududuru et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARγ, and inhibitors of autotaxin
GG Durgam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D
S Jansen et al.
JOURNAL OF CELL SCIENCE (2005)
Expression, regulation and function of autotaxin in thyroid carcinomas
A Kehlen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site
R Gijsbers et al.
FEBS LETTERS (2003)
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
A Tokumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hydroxamic acids as pharmacological agents
EMF Muri et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
M Umezu-Goto et al.
JOURNAL OF CELL BIOLOGY (2002)
Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells
SW Nam et al.
ONCOGENE (2000)
Share Paper
